Yevgeniy Samyshkin

Author PubWeight™ 0.81^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US.	J Med Econ	2012	0.81